Methadone Patient Access to Collaborative Treatment
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- University of Arizona
- Study ID
- NCT06556602
- Status
- Recruiting
Conditions
- Opioid Use Disorder
- Patients
- Staff
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- MPACT — OTHERFour components are part of this intervention: 1) accredited training about patient centered, trauma-informed care and the standard of care under the current federal regulation (42CFRpart8), 2) education about trauma and trauma symptoms including vicarious (work related) trauma and navigation to symptoms screening and resources including treatment, 3) reflective supervision for counseling, case management and peer staff, and 4) clinic self assessment for trauma-informed and patient centered care
Study Details
The trial of Methadone Patient Access to Collaborative Treatment (MPACT) will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose. It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation.
Key Dates
- First listed
- Aug 16, 2024
- Start date
- Feb 5, 2026
- Status verified
- Jul 2026
- Primary completion
- Apr 30, 2029
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 1,080 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: MPACT InterventionEnrolled clinic staff will be exposed to the MPACT intervention components over the trial period. This includes accredited training, clinic self assessment, reflective supervision for counseling/peer/case management staff, and wellness education with navigation to trauma symptoms assessment and resources including trauma treatment. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
- No Intervention: Control for MPACTEnrolled clinic staff will not receive any portion of the intervention. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
Primary Outcome Measure
Days in Treatment to treatment interruption [ Time Frame: 18 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Arizona College of Nursing | Tucson | Arizona | 85714 | Beth Meyerson, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Tucson, AZ
By research site
Related Studies
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Phoenix, Arizona
- Mindfulness-Based Ecological Momentary Intervention for Opioid Use Disorder and Chronic PainRecruiting · Arizona State University · Phoenix, Arizona
- A Study of Brenipatide in Participants With Opioid Use DisorderPHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- Houston Emergency Opioid Engagement SystemPHASE4 · Enrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas